Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05516004 · ClinicalTrials.gov registry record · Phase 2
Safety and Effectiveness of the PXL-Platinum 330 System for Cornea Crosslinking in Eyes With Cornea Thinning
A Phase 2 study of Keratoconus, sponsored by Cohen Laser and Vision Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT05516004 is a Phase 2 study of Keratoconus that is actively recruiting participants, run by Cohen Laser and Vision Center. The registered enrollment target is 300 participants, below the 1,166-participant average among 21 other Keratoconus trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05516004, a Phase 2 study of Keratoconus, is actively recruiting participants, sponsored by Cohen Laser and Vision Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
This study study is to determine the effectiveness of cornea cross linking in patients with Keratoconus or other cornea thinning conditions.
Conditions Studied
Interventions
- DEVICE PXL Platinum 330 system
Study Locations (1)
Florida
- Cohen Laser and Vision Center - Boca Raton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-07-01 |
| Est. Completion | 2034-06-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05516004
The ClinicalTrials.gov registry entry for NCT05516004 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,166-participant average among 21 other Keratoconus trials with a reported enrollment target (74% lower). The listed sponsor is Cohen Laser and Vision Center, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Keratoconus appearing as the primary indexed condition, and to 1 intervention - of which PXL Platinum 330 system is the first listed.
NCT05516004 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05516004 about?
NCT05516004 is a clinical study titled "Safety and Effectiveness of the PXL-Platinum 330 System for Cornea Crosslinking in Eyes With Cornea Thinning". This study study is to determine the effectiveness of cornea cross linking in patients with Keratoconus or other cornea thinning conditions.
What is the current status of trial NCT05516004?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 300 participants. The study started on 2024-07-01. Estimated completion is 2034-06-01.
What conditions does trial NCT05516004 study?
This clinical trial studies the following conditions: Keratoconus.
What interventions are being tested in trial NCT05516004?
The interventions under investigation include: PXL Platinum 330 system (DEVICE).
Who is sponsoring clinical trial NCT05516004?
This trial is sponsored by Cohen Laser and Vision Center, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05516004 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Keratoconus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus
RECRUITING · Phase 2
-
Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia
RECRUITING · Phase 2
-
Comparison of Standard vs. Accelerated Corneal Crosslinking
RECRUITING · Phase 2
-
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
RECRUITING
-
OCT in Diagnosis of Irregular Corneas
RECRUITING
-
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.